An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Drug Gaining Traction Online
Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining discount codes.
Thriving Commerce on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before redirecting customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Experts Express Worries
However, physicians and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering products of uncertain source.
Several experts stated the popularity for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the British medical regulations.
Some influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.
Service Reaction and Content Removal
According to the social media company, the service has removed problematic content and prohibited associated hashtags and search suggestions. The company said it was committed to keeping the service secure and investing in strengthening enforcement strategies.
Online Marketplace Operations
Research also found communities with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at home.
Within minutes of entering one group, a seller posted WhatsApp details, where most transactions take place. The vendor sent an instruction manual and promised shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.
Item Information and Pricing
Inside these groups, messages display black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or pre-filled pens typically sold at £160 for 20mg. When questioned how much time a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting substances they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her team has previously seen individuals harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject users to possibly significant health risks”.
